Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Common Equity (2016 - 2026)

Healthcare Services has reported Common Equity over the past 18 years, most recently at $513.8 million for Q1 2026.

  • Quarterly Common Equity changed 0.08% to $513.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $513.8 million through Mar 2026, changed 0.08% year-over-year, with the annual reading at $510.2 million for FY2025, 2.06% up from the prior year.
  • Common Equity was $513.8 million for Q1 2026 at Healthcare Services, up from $510.2 million in the prior quarter.
  • Over five years, Common Equity peaked at $514.2 million in Q1 2025 and troughed at $418.3 million in Q4 2022.
  • The 5-year median for Common Equity is $471.4 million (2024), against an average of $466.7 million.
  • Biggest five-year swings in Common Equity: dropped 12.11% in 2022 and later rose 12.89% in 2024.
  • Tracing HCSG's Common Equity over 5 years: stood at $418.3 million in 2022, then increased by 9.17% to $456.6 million in 2023, then rose by 9.49% to $499.9 million in 2024, then rose by 2.06% to $510.2 million in 2025, then increased by 0.7% to $513.8 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $513.8 million, $510.2 million, and $496.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.